|
CHMP2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.558400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.816100E-02 |
| Normal-vs-Stage2 |
7.746400E-01 |
| Normal-vs-Stage3 |
2.750800E-01 |
| Normal-vs-Stage4 |
1.180310E-03 |
| Stage1-vs-Stage2 |
7.425800E-01 |
| Stage1-vs-Stage3 |
9.360600E-01 |
| Stage1-vs-Stage4 |
1.428390E-01 |
| Stage2-vs-Stage3 |
7.342400E-01 |
| Stage2-vs-Stage4 |
1.521160E-01 |
| Stage3-vs-Stage4 |
1.897830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.029800E-02 |
| Normal-vs-AfricanAmerican |
2.921200E-01 |
| Normal-vs-Asian |
4.451200E-01 |
| Caucasian-vs-AfricanAmerican |
7.566600E-01 |
| Caucasian-vs-Asian |
6.938800E-01 |
| AfricanAmerican-vs-Asian |
6.106400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.058120E-02 |
| Normal-vs-Female |
4.424400E-01 |
| Male-vs-Female |
2.802800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.156100E-02 |
| Normal-vs-Extreme_Weight |
1.227510E-02 |
| Normal-vs-Obese |
6.532400E-01 |
| Normal-vs-Extreme_Obese |
8.532200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.891800E-01 |
| Normal_Weight-vs-Obese |
1.713380E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.361400E-01 |
| Extreme_Weight-vs-Obese |
1.017600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.014400E-01 |
| Obese-vs-Extreme_Obese |
9.931200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.269400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.175820E-01 |
| Normal-vs-Age(61-80Yrs) |
1.167760E-01 |
| Normal-vs-Age(81-100Yrs) |
1.921430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.000400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.782400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.905000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.463800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.220810E-01 |
| Normal-VS-Type2 PRCC |
1.215010E-01 |
| Normal-VS-KIRP CIMP |
1.443980E-01 |
| Normal-VS-Unclassified PRCC |
1.724560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.904000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.368600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.804600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.403800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.455000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.992000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.044320E-03 |
| Normal-vs-N1 |
5.298600E-01 |
| Normal-vs-N2 |
5.039800E-03 |
| N0-vs-N1 |
1.056200E-01 |
| N0-vs-N2 |
5.538400E-01 |
| N1-vs-N2 |
2.218800E-01 |
|
|
